Results 161 to 170 of about 9,342,565 (376)

PB1728: CRESCENDO IMPROVEMENT OF SURVIVAL FOR ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA DURING PAST TWO DECADES: A 1000 CASES COHORT IN A SINGLE CENTER

HemaSphere, 2023
Junjie Chen, Zhixiang Wang, Jia LI, Yang Zhou, Haimei Liang, Qifa Liu, Hongsheng Zhou   +6 more
doaj   +1 more source

PD-1 blockade immunotherapy as a successful rescue treatment for disseminated adenovirus infection after allogeneic hematopoietic stem cell transplantation

Journal of Hematology & Oncology
Disseminated adenovirus infection is a complication with a relatively high mortality rate among patients undergoing hematopoietic stem cell transplantation.
Fei Zhou, Feng Du, Ziyan Wang, Mengxing Xue, Depei Wu, Suning Chen, Xuefeng He   +6 more
doaj   +1 more source

Clinical application value of metagenomic second-generation sequencing technology in hematologic diseases with and without transplantation. [PDF]

Front Cell Infect Microbiol, 2023
Zhang X, Wang F, Yu J, Jiang Z.
europepmc   +1 more source

Sonodynamic and Bioorthogonal Sonocatalytic Thrombotic Therapy Based on AIE Cationic Tetranuclear Ir(III) Complex Nanoplatform Guided by NIR‐Chemiluminescence Imaging

Advanced Materials, EarlyView.
AIE‐active tetranuclear Ir(III) complex Ir‐4 as a sonosensitizer/sonocatalyst is formulated into a nanoplatform with an H2S donor. Ir‐4@S‐R NPs achieves combined endogenous NIR chemiluminescence imaging, sonodynamic therapy and release of H2S in situ by a bioorthogonal sonocatalytic reaction in vivo, achieving safe thrombolysis and anti‐inflammatory ...
Zihan Wu, Liping Zhang, Ziwei Wang, Shengnan Liu, Qiaohua Zhang, Chunguang Shi, Yachao Wang, Gelin Xu, Dongxia Zhu, Martin R. Bryce, Lijie Ren, Ben Zhong Tang   +11 more
wiley   +1 more source

Olverembatinib (HQP1351)-based therapy in adults with relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia or chronic myeloid leukemia in blast phase: results from a real-world study

Frontiers in Immunology
BackgroundRelapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia (R/R Ph+ ALL) and chronic myeloid leukemia in the blast phase (CML-BP) are associated with poor prognoses.
Ziyu Wen, Zhi Liu, Xu Ye, Zhiping Fan, Zhiping Fan, Ren Lin, Ren Lin, Fen Huang, Fen Huang, Li Xuan, Li Xuan, Xiaofang Li, Xiaofang Li, Hua Jin, Hua Jin, Min Dai, Min Dai, Jing Sun, Jing Sun, Xuan Zhou, Xuan Zhou, Qiang Wang, Qiang Wang, Xiaoli Liu, Xiaoli Liu, Qifa Liu, Qifa Liu, Hongsheng Zhou, Hongsheng Zhou, Na Xu, Na Xu   +30 more
doaj   +1 more source

Outcomes of allogeneic stem cell transplantation for patients with hematologic diseases ≥60 years old. [PDF]

Blood Cell Ther, 2023
Shima T, Takigawa K, Utsumi S, Yoshino T, Naganuma M, Minami M, Hayashi M, Matsuo Y, Kuriyama T, Eto T.   +9 more
europepmc   +1 more source

Relationship between Hematological Parameters and Incidence of Ischemic Heart Diseases among Japanese White‐Collar Male Workers [PDF]

, 2001
Toshio Kobayashi, Yuji Miyosht, Kazue Yamaoka, Eiji Yano   +3 more
openalex   +1 more source

Hematological Diseases and Apoptosis.

Internal Medicine, 1998
Terutoshi Hishita, Yataro Yoshida, Hiroshi Kawabata, Mayumi Dodo, Naoyuki Anzai, Kaoru Tohyama   +5 more
openaire   +4 more sources

Reengineering Endogenous Targeting Lipid Nanoparticles (ENDO) for Systemic Delivery of mRNA to Pancreas

Advanced Materials, EarlyView.
ENDO lipid nanoparticles containing cholecalciferol as a fifth component demonstrate mRNA delivery to the pancreas with 99% selectivity, including beta cells. This platform shows minimal toxicity and sustained protein expression for up to 3 days in a dose‐dependent manner, offering a novel approach to pancreas‐specific mRNA delivery and gene therapy ...
Ivan Isaac, Luv Patel, Nguyen Tran, Amarnath Singam, DongSoo Yun, Prasun Guha, Seungman Park, Chandrabali Bhattacharya   +7 more
wiley   +1 more source

Application of omics in the diagnosis, prognosis, and treatment of acute myeloid leukemia

Biomarker Research
Acute myeloid leukemia (AML) is the most frequent leukemia in adults with a high mortality rate. Current diagnostic criteria and selections of therapeutic strategies are generally based on gene mutations and cytogenetic abnormalities.
Zhiyu Zhang, Jiayi Huang, Zhibo Zhang, Hongjie Shen, Xiaowen Tang, Depei Wu, Xiebing Bao, Guoqiang Xu, Suning Chen   +8 more
doaj   +1 more source